Chaping Cheng

State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200127, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

The Zeb1/system Xc- axis safeguards iron-loaded cancer-associated fibroblasts against ferroptosis and promotes immunosuppression in prostate cancer.

The Zeb1/system Xc- axis safeguards iron-loaded cancer-associated fibroblasts against ferroptosis and promotes immunosuppression in prostate cancer.

Journal: Cancer letters
Published: July 16, 2025

O-GalNAc Glycosylation Activates MBL-Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis.

O-GalNAc Glycosylation Activates MBL-Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 17, 2025

5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis.

5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis.

Journal: The Journal of clinical investigation
Published: June 03, 2024

A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway.

A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathway.

Journal: Nature cancer
Published: April 09, 2024

Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer.

Iron-loaded cancer-associated fibroblasts induce immunosuppression in prostate cancer.

Journal: Nature communications
Published: January 05, 2024

Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.

Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of neuroendocrine prostate cancer.

Journal: Cell death and differentiation
Published: October 13, 2023

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.

ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers.

Journal: The Journal of clinical investigation
Published: January 10, 2023

IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer.

IL-1β Is an Androgen-Responsive Target in Macrophages for Immunotherapy of Prostate Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 23, 2022

Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.

Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation.

Journal: Cell reports
Published: May 03, 2022

Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer.

Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer.

Journal: Nature cancer
Published: March 18, 2021

A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication.

A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour-immune cell communication.

Journal: Cell proliferation
Published: February 02, 2021

Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate.

Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate.

Journal: Nature communications
Published: January 20, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026